Overview
Rachel Freedman is an Oncologist practicing medicine in Chestnut Hill, Massachusetts.
Dr. Freedman is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Breast Cancer in Men, Angiosarcoma, and Inflammatory Breast Cancer.
She is actively involved in clinical research, co-authoring 177 peer reviewed articles and participating in 13 clinical trials. Dr. Freedman is currently accepting new patients.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
300 Boylston St, Chestnut Hill, MA 02467
450 Brookline Ave, Boston, MA 02215
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
11 Clinical Trials
Dana-Farber Cancer Institute-Chestnut Hill
Bradley Mcgregor is an Oncologist practicing medicine in Chestnut Hill, Massachusetts. Dr. Mcgregor is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Urothelial Cancer, Muscle Invasive Bladder Cancer, Tissue Biopsy, and Nephrectomy. Dr. Mcgregor is currently accepting new patients.
Dana-Farber Cancer Institute, Breast Oncology Program
Dr. Tolaney is Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, and Associate Professor of Medicine at Harvard Medical School. She is a breast medical oncologist whose research focuses on the development of novel therapies in the treatment of breast cancer. She has been instrumental in developing several treatment approaches for breast cancer, including approaches focused on tailoring therapy for early stage HER2+ disease, use of cdk 4/6 inhibitors, antibody drug conjugates, and immunotherapy.She is a member of the National Cancer Institute Breast Cancer Steering Committee and is Vice Chair for Late-Stage Development in Breast Cancer in the Alliance for Clinical Trials in Oncology. Her research has been funded by the Breast Cancer Research Foundation and Susan G. Komen. She currently chairs multiple phase 3 trials in breast cancer and serves on several steering committees for practice-changing trials. Her work has been published in journals such as the New England Journal of Medicine, Lancet, Lancet Oncology, Journal of Clinical Oncology, and others. She received her undergraduate degree from Princeton University in 1998 and her medical degree from UC San Francisco in 2002. She subsequently completed her residency in Internal Medicine at Johns Hopkins University, and fellowships in hematology and medical oncology at Dana-Farber Cancer Institute. She obtained a Masters in Public Health from the Harvard School of Public Health in 2007. In 2008, she joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital. Dr. Tolaney is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Triple-Negative Breast Cancer. Dr. Tolaney is board certified in Medical Oncology. Dr. Tolaney is currently accepting new patients.
Dana-Farber Cancer Institute
Matthew Davids is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Davids is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Aspiration, and Tissue Biopsy. Dr. Davids is currently accepting new patients.
Dana-Farber Cancer Institute, Breast Oncology Program
Dr. Lin is a medical oncologist specializing in the care of patients with all stages of breast cancer. Her research focuses upon improving the outcomes of people living with metastatic breast cancer, including a particular focus on the challenge of breast cancer brain metastases. She has led multiple clinical trials which have led to new treatment options for patients with breast cancer that has metastasized to the brain. Dr. Lin received her MD from Harvard Medical School in 1999. She completed her residency in internal medicine at Brigham and Women's Hospital and went on to complete fellowships in medical oncology and hematology at Dana-Farber. In 2005, she joined the staff of Brigham and Women's and Dana-Farber, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. Dr. Lin is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Brain Tumor, and Inflammatory Breast Cancer. Dr. Lin is board certified in Medical Oncology. Dr. Lin is currently accepting new patients.
Dana-Farber Cancer Institute, Center For Neuro-Oncology
David Reardon is a Hematologist Oncology specialist and a Hematologist practicing medicine in Boston, Massachusetts. Dr. Reardon is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Tissue Biopsy. Dr. Reardon is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Reardon is currently accepting new patients.
Dana-Farber Cancer Institute
Toni Choueiri is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Choueiri is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Choueiri is currently accepting new patients.
Frequently Asked Questions about Dr. Rachel A. Freedman
How do I make an appointment with Dr. Rachel A. Freedman?
You can book an appointment with Dr. Rachel A. Freedman by calling their office at 617-632-3000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Rachel A. Freedman a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Rachel A. Freedman is classified as an Elite expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Rachel A. Freedman specialize in?
While Dr. Rachel A. Freedman is a Oncology, they have specific expertise in Breast Cancer, Breast Cancer in Men, and Angiosarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Rachel A. Freedman participate in research or clinical trials?
Yes. Dr. Rachel A. Freedman has published 177 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Rachel A. Freedman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Rachel A. Freedman accept my insurance?
Dr. Rachel A. Freedman accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 617-632-3000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Freedman isElite. Learn about Breast Cancer.
- Distinguished
- AngiosarcomaDr. Freedman isDistinguished. Learn about Angiosarcoma.
- Breast Cancer in MenDr. Freedman isDistinguished. Learn about Breast Cancer in Men.
- Inflammatory Breast CancerDr. Freedman isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Freedman isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Brain TumorDr. Freedman isAdvanced. Learn about Brain Tumor.
- HER-2 Positive Breast CancerDr. Freedman isAdvanced. Learn about HER-2 Positive Breast Cancer.
- Experienced
- HER2 Negative Breast CancerDr. Freedman isExperienced. Learn about HER2 Negative Breast Cancer.
- LeukemiaDr. Freedman isExperienced. Learn about Leukemia.
- Lung CancerDr. Freedman isExperienced. Learn about Lung Cancer.
- MenopauseDr. Freedman isExperienced. Learn about Menopause.
- PIK3CA-Related Overgrowth SpectrumDr. Freedman isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.
- Triple-Negative Breast CancerDr. Freedman isExperienced. Learn about Triple-Negative Breast Cancer.

